CERS Stock Analysis: Buy, Sell, or Hold?
CERS - Cerus Corp
$1.86
-0.01 (-0.53%)
▼
5d:
+1.64%
30d:
-16.96%
90d:
-9.71%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
CERS is down 16.5% this week, but smart money is accumulating calls. Top strike: $2 2026-05-15 with 715 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When CERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CERS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CERS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CERS is currently trading at $1.86, which is considered slightly low relative to its 30-day fair value range of $1.70 to $2.30. From a valuation perspective, the stock is trading at a discount (Forward PE: -372.0) compared to its historical average (81.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CERS is in a downtrend. The price is approaching resistance at $1.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CERS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+168.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CERS is in a downtrend. The price is approaching resistance at $1.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CERS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+168.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.70 -
$2.30
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 168.8% below Wall St target ($5.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fair Price Analysis
30-Day Fair Range
$1.70 -
$2.30
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.68
Resistance Level
$1.92
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-372.00
Wall Street Target
$5.00
(+168.8%)
Revenue Growth (YoY)
13.7%
Profit Margin
-7.6%
PE vs Historical
-372.0 vs 81.2
CHEAP
Share & Embed Analysis
Last updated: April 02, 2026 7:24 PM ET
Data refreshes hourly during market hours. Next update: 8:24 PM
Data refreshes hourly during market hours. Next update: 8:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Dennis Green
SELL
127544 shares
2026-03-12
Richard J Benjamin
SELL
101740 shares
2026-03-12
Vivek K Jayaraman
SELL
165200 shares
2026-03-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
